7.00
-0.13 (-1.82%)
-0.13 (-1.82%)
Upgrade to Real-Time
Afterhours
Best deals to access real time data! |
Big Cap Pro
Monthly Subscription
for only
|
Small Cap Basic
Monthly Subscription
for only
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
VAT not included
|
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Nemaura Medical Inc | NMRD | NASDAQ | Common Stock |
Price Change | Change Percent | Stock Price | Last Traded ![]() |
|
---|---|---|---|---|
-0.13 | -1.82% | 7.00 | 17:54:17 |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
7.13 | 6.9852 | 7.564 | 7.15 | 7.13 |
Bid Price | Ask Price | Spread | News | |
---|---|---|---|---|
6.50 | 7.14 | 0.64 | - | - |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
695 | 79,130 | $ 7.23 | $ 571,759 | 63,202 | 3.1173 - 16.50 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
17:50:44 | 29 | $ 7.03 | USD |
Nemaura Medical Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 160.26M | 22.89M | 6.61M | $ - | $ - | -0.29 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | $ - | 0.00% | - | 57.00% |
Nemaura Medical News
Date | Time | Source | News Article |
---|---|---|---|
2/16/2021 | 08:50 | Seeking Alpha | Nemaura Medical reports Q3 results |
2/16/2021 | 08:30 | GlobeNewswire Inc. | Nemaura Medical Reports Financial Results for Third Quarter.. |
2/12/2021 | 17:43 | Edgar (US Regulatory) | Quarterly Report (10-q) |
2/11/2021 | 08:45 | GlobeNewswire Inc. | Nemaura Medical Secures $20 Million Non-Dilutive Loan to.. |
2/11/2021 | 08:00 | Edgar (US Regulatory) | Current Report Filing (8-k) |
2/08/2021 | 06:51 | Seeking Alpha | Nemaura Medical rises 67% in premarket |
2/04/2021 | 08:30 | GlobeNewswire Inc. | Nemaura Medical Appoints Thomas Mortensen as Head of E.U... |
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NMRD Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 7.71 | 8.165 | 6.8852 | 7.59 | 162,911 | -0.71 | -9.21% |
1 Month | 4.58 | 12.59 | 4.15 | 8.76 | 566,283 | 2.42 | 52.84% |
3 Months | 3.96 | 12.59 | 3.45 | 8.06 | 241,202 | 3.04 | 76.77% |
6 Months | 5.01 | 12.59 | 3.1173 | 7.23 | 133,049 | 1.99 | 39.72% |
1 Year | 3.16 | 16.50 | 3.1173 | 7.50 | 94,696 | 3.84 | 121.52% |
3 Years | 5.16 | 16.50 | 0.383 | 4.10 | 77,728 | 1.84 | 35.66% |
5 Years | 5.66 | 16.50 | 0.383 | 4.12 | 76,337 | 1.34 | 23.67% |
Nemaura Medical Description
Nemaura Medical Inc is a medical technology company developing sugarBEAT as a non-invasive, affordable and flexible Continuous Glucose Monitor (CGM) designed for people with diabetes and pre-diabetics to manage their glucose levels. Insulin users can adjunctively use sugarBEAT when calibrated with a finger-stick glucose reading. SugarBEAT consists of a daily disposable adhesive skin-patch connected to a rechargeable transmitter with an app displaying glucose readings at five minute intervals for periods up to 24 hours. |